Kevin Tan
2021
In 2021, Kevin Tan earned a total compensation of $2.6M as Chief Financial Officer at SELECTA BIOSCIENCES.
Compensation breakdown
| Bonus | $75,000 |
|---|---|
| Non-Equity Incentive Plan | $46,280 |
| Option Awards | $2,369,619 |
| Salary | $110,385 |
| Other | $338 |
| Total | $2,601,622 |
Tan received $2.4M in option awards, accounting for 91% of the total pay in 2021.
Tan also received $75K in bonus, $46.3K in non-equity incentive plan, $110.4K in salary and $338 in other compensation.
Rankings
In 2021, Kevin Tan's compensation ranked 5,005th out of 12,412 executives tracked by ExecPay. In other words, Tan earned more than 59.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,005 out of 12,412 | 60th |
Division Manufacturing | 2,103 out of 5,498 | 62nd |
Major group Chemicals And Allied Products | 898 out of 2,374 | 62nd |
Industry group Drugs | 803 out of 2,095 | 62nd |
Industry Pharmaceutical Preparations | 572 out of 1,542 | 63rd |
Source: SEC filing on May 3, 2022.
Tan's colleagues
We found six more compensation records of executives who worked with Kevin Tan at SELECTA BIOSCIENCES in 2021.
2021
Carsten Brunn
SELECTA BIOSCIENCES
Chief Executive Officer
2021
Peter Traber
SELECTA BIOSCIENCES
Chief Medical Officer
2021
Takashi Kishimoto
SELECTA BIOSCIENCES
Chief Scientific Officer
2021
Lloyd Johnston
SELECTA BIOSCIENCES
Chief Operations Officer
2021
Bradford Dahms
SELECTA BIOSCIENCES
Chief Financial Officer
2021
Ann Donohue
SELECTA BIOSCIENCES